However, this cannot be the unique factor affecting CD34+ mobilization, since constitutive p-STAT5 is also active in progenitor cells of PV and ET patients [8], in whom this phenomenon is not detectable, at least in the chronic phase of the disease. Here, STAT5B is linked to essential thrombocythemia.